News

NICE Rejects Bevacizumab for Bowel Cancer
Elsevier Global Medical News, 2010 Aug 24, J Smith
Non–AIDS-Defining Cancers Rising in HIV Patients
Elsevier Global Medical News, 2010 Jul 29, ML Zoler
Cetuximab Fails to Add Benefit to Frontline Therapy for Metastatic CRC
Elsevier Global Medical News, 2010 Jun 29, N Osterweil
Bevacizumab Maintenance Falls Short of Statistical Goal
Elsevier Global Medical News, 2010 Jun 25, N Osterweil

Chemotherapy Regimens

Irinotecan, leucovorin, 5-fluorouracil +or- cetuximab combinations (Colon, rectum, and anus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
XELOX (capecitabine [Xeloda], oxaliplatin) (Colon, rectum, and anus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Panitumumab (Colon, rectum, and anus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Mitomycin, 5-fluorouracil (5-FU) (Colon, rectum, and anus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Irinotecan (Colon, rectum, and anus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)

Conference Coverage

ASCO 2009 Gastrointestinal Cancers Symposium
January 15-17 2009 San Francisco CA

Videos

Adult Survivors of Childhood Cancer
Elsevier Global Medical News, 2009 Jun 1, D McNamara
Panitumumab Skin Toxicity
Elsevier Global Medical News, 2009 Jun 1, D McNamara
Adjuvant Bevacizumab in Colon Ca
Elsevier Global Medical News, 2009 Jun 1, D McNamara
Role of DNA-Based Test As CRC Screen
Elsevier Global Medical News, 2008 Sept 25, SL Zoler
KRAS Status Predicts Response to Cetuximab/FOLFIRI
ASCO, 2008 Jun 1, Mary Ellen Schneider

Summary of Key Points

Cancer of the Small Bowel
Abeloff's Clinical Oncology, 4th ed. 2008
Cancers of the Colon and Rectum
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Colon and Rectum Cancer

Summary information about colon and rectum cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.

Cancer Policy Forum

Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration